Breaking News

Millipore To Develop Serum-Free Media for SCS

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Stem Cell Sciences (SCS) has entered an exclusive license agreement for Millipore to develop and market SCS’ serum-free media for the growth of human embryonic stem cells (hESCs). This media will be the first product available in the industry that offers improved methods for growing hESCs without the need for animal serum. Researchers can generate improved experimental results by avoiding interference from animal products in the media, which will also improve the reliability in growin...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters